As per Data Bridge Market Research analysis the omeprazole market was valued at USD 3.28 billion in 2025 and is projected to reach USD 4.28 billion by 2033, growing at a CAGR of 3.40% from 2026 to 2033.
The market is experiencing steady growth driven by the increasing prevalence of gastroesophageal reflux disease (GERD), peptic ulcers, and acid-related gastrointestinal disorders, along with rising demand for effective proton pump inhibitor (PPI) therapies across hospital and retail healthcare settings.
The growing aging population, increasing use of non-steroidal anti-inflammatory drugs (NSAIDs), and expanding access to generic pharmaceutical products are encouraging healthcare providers to prescribe omeprazole for long-term acid suppression and ulcer prevention, supporting continued market expansion.